 Eyegate Pharmaceuticals NASDAQ: EYEG shares are trading higher Monday afternoon after the company announced it entered a non-binding letter of intent to acquire Bayon Therapeutics for roughly 7.1 million. Bayon Therapeutics is an ophthalmic specialty pharmaceutical company. 